Entero Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
36.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-0.32
|
-0.59
|
-0.27
|
-83.00%
|
|
2024-06-30
|
0.00
|
-3.86
|
0.00
|
0.00%
|
|
2024-03-31
|
-2.43
|
0.38
|
2.81
|
115.64%
|
|
2023-12-31
|
-4.03
|
-5.35
|
-1.32
|
-32.75%
|
|
2023-09-30
|
-12.30
|
-9.20
|
3.10
|
25.20%
|
|
2023-06-30
|
-20.80
|
-37.80
|
-17.00
|
-81.73%
|
|
2023-03-31
|
0.00
|
-36.46
|
0.00
|
0.00%
|
|
2022-12-31
|
0.00
|
-80.08
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-4.06
|
|
2023-12-31
|
-88.81
|
|
2022-12-31
|
-3571.24
|
|
2021-12-31
|
-46506.06
|
|
2020-12-31
|
-61359.45
|
|
2019-12-31
|
-30451.15
|
|
2018-12-31
|
-37273.20
|
|
2017-12-31
|
-57670.79
|